EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY-NC 4.0

PBPK modeling: What is the role of CYP3A4 expression in the gastrointestinal tract to accurately predict first‐pass metabolism?

Justine Henriot iD, André Dallmann iD, François Dupuis iD, Jérémy Perrier iD, Sebastian Frechen iD

CPT: Pharmacometrics & Systems Pharmacology · 2025

DOI: 10.1002/psp4.13249 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift CPT: Pharmacometrics & Systems Pharmacology, 2025. Verfasst von Justine Henriot und 4 weiteren Autor:innen. Beteiligte Einrichtung: Université de Lorraine, Faculty of Pharmacy, Nancy, France. Hauptthemen laut MEDLINE: Biological Availability, Cytochrome P-450 CYP3A, Gastrointestinal Tract, Models, Biological. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gastrointestinal first‐pass metabolism plays an important role in bioavailability and in drug–drug interactions. Physiologically‐based pharmacokinetic (PBPK) modeling is a powerful tool to integrate these processes mechanistically. However, a correct bottom‐up prediction of GI first‐pass metabolism is challenging and depends on various model parameters like the level of enzyme expression and the basolateral intestinal mucosa permeability ( P mucosa ). This work aimed to investigate if cytochrome P450 (CYP) 3A4 expression could help predict the first‐pass effect using PBPK modeling or whether additional factors like P mucosa do play additional roles using PBPK modeling. To this end, a systematic review of the absolute CYP3A expression in the human gastrointestinal tract and liver was conducted. The resulting CYP3A4 expression profile and two previously published profiles were applied to PBPK models of seven CYP3A4 substrates (alfentanil, alprazolam, felodipine, midazolam, sildenafil, triazolam, and verapamil) built‐in PK‐Sim®. For each compound, it was assessed whether first‐pass metabolism could be adequately predicted based on the integrated CYP3A4 expression profile alone or whether an optimization of P mucosa was required. Evaluation criteria were the precision of the predicted interstudy bioavailabilities and area under the concentration–time curves. It was found that none of the expression profiles provided upfront an adequate description of the extent of GI metabolism and that optimization of P mucosa as a compound‐specific parameter improved the prediction of most models. Our findings indicate that a pure bottom‐up prediction of gastrointestinal first‐pass metabolism is currently not possible and that compound‐specific features like P mucosa must be considered as well.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biological AvailabilityCytochrome P-450 CYP3AGastrointestinal TractModels, BiologicalHumansAlfentanilAlprazolamComputer SimulationDrug InteractionsFelodipineIntestinal MucosaLiverMidazolamTriazolamVerapamil

Substanzen

AlfentanilAlprazolamCYP3A4 protein, humanCytochrome P-450 CYP3AFelodipineMidazolamTriazolamVerapamil

Autor:innen und Institutionen

  • Université de Lorraine, Faculty of Pharmacy, Nancy, France.
  • Bayer AG, Pharmacometrics/Modeling and Simulation, Systems Pharmacology & Medicine - PBPK, Leverkusen, Germany.
  • Bayer HealthCare SAS (on behalf of Bayer AG, Model-Informed Drug Development (MIDD), Research & Development Pharmaceuticals, Leverkusen, Germany), Lille, France.
  • Université de Lorraine, CITHEFOR, Nancy, France.
  • PhinC Development, Massy, France.

ORCID-Profile: Justine Henriot, André Dallmann, François Dupuis, Jérémy Perrier, Sebastian Frechen

Zitieren

APA

Henriot, J., Dallmann, A., Dupuis, F., Perrier, J., & Frechen, S. (2025). PBPK modeling: What is the role of CYP3A4 expression in the gastrointestinal tract to accurately predict first‐pass metabolism?. CPT: Pharmacometrics & Systems Pharmacology. https://doi.org/10.1002/psp4.13249

Vancouver

Henriot J, Dallmann A, Dupuis F, Perrier J, Frechen S. PBPK modeling: What is the role of CYP3A4 expression in the gastrointestinal tract to accurately predict first‐pass metabolism?. CPT: Pharmacometrics & Systems Pharmacology. 2025. doi:10.1002/psp4.13249

BibTeX
@article{Henriot2025,
  author = {Henriot, Justine and Dallmann, André and Dupuis, François and Perrier, Jérémy and Frechen, Sebastian},
  title = {PBPK modeling: What is the role of CYP3A4 expression in the gastrointestinal tract to accurately predict first‐pass metabolism?},
  journal = {CPT: Pharmacometrics & Systems Pharmacology},
  year = {2025},
  doi = {10.1002/psp4.13249}
}
Kostenlos starten →